Replimune to resubmit twice-rejected drug for approval after FDA shakeup
Replimune was among the drugmakers that had criticized the FDA for what they called inconsistent guidance around trials and approvals.
المزيد من أخبار الأعمال
Automakers like Rivian and Ford are ‘democratizing 3D printing’ to reduce costs and increase speed
Automakers including Ford, Rivian and GM are expanding 3D printing to make prototypes, factory tools and low-volume parts faster and at lower cost.
Cheaper cars are selling considerably faster than at the beginning of the year
Data indicate cheap cars are selling fast, but a few lower-priced segments still saw sales drop in the third quarter. Here's what might be happening.
Rivian third-quarter earnings beat estimates as software revenue, R2 deliveries rise
Rivian also revised its 2026 guidance to mark expected improvements in its vehicle deliveries, pre-tax adjusted earnings and capital expenditures.
Starbucks is about to report earnings. Here's what to expect
Starbucks stock has climbed about 24% this year, raising its market cap to roughly $119 billion.